Terms of Service

NeoAmorfic Ltd · last updated 3 July 2026

1. Who provides the service

QEIv18™ Gold Risk Intelligence (the "Service") is provided by NeoAmorfic Ltd, a company registered in England and Wales (company number 16108719; registered office: 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom) ("NeoAmorfic", "we"). By accessing the Service — the public website, the delayed open record, a trial, or a subscription — you agree to these terms. Institutional subscriptions may additionally be governed by an order form or master agreement, which prevails over these terms where they differ.

2. What the Service is — and is not

The Service is an information service. It publishes a deterministic, two-state structural reading (INVESTED / HEDGED) of specified exchange-traded instruments, together with historical research figures and a sealed audit record. It is not investment advice, a personal recommendation, portfolio management, brokerage, or an offer or solicitation to buy or sell any investment. The Service does not consider your circumstances, objectives, or exposures. All trading, hedging, and investment decisions — including whether and how to act on any state — are made solely by you, under your own policy and at your own risk.

The Service is intended for professional and institutional use only. By subscribing you confirm you are acting in the course of business and not as a retail consumer.

3. Access, accounts, and licence

4. Fees and term

Fees, term, and renewal are as agreed in the applicable order or invoice. Unless otherwise agreed, fees are payable in advance and are non-refundable except where required by law. Access ends automatically at the end of the paid term unless renewed.

5. Intellectual property

The Service, its methodology, software, records, documentation, and the neoamorfic™ and QEIv18™ marks are and remain the property of NeoAmorfic and its licensors. Nothing in these terms transfers any ownership. Documents supplied to a subscriber (including per-instrument analyses) are provided for that institution's internal use and may not be redistributed publicly.

6. Data and privacy

Our handling of personal data is described in the Privacy Policy, which forms part of these terms.

7. Important disclaimers

8. Market data

The Service is computed from market data supplied by third-party providers (currently Databento, for CME Globex settlement data). The historical certified record was computed on that provider's data as normalised at the time of the audit.

Market-data providers may revise their normalisation, coverage, corrections or methodology at any time, and NeoAmorfic may change provider. Figures recomputed under a different provider or a revised normalisation may differ from those published. NeoAmorfic does not control upstream data and accepts no liability for changes, errors, delays, revisions or discontinuations made by any market-data provider, nor for any consequence of such changes. Where a change materially affects the record, NeoAmorfic will note it in the provenance chain rather than silently restate published figures.

9. Liability

Nothing in these terms excludes liability that cannot be excluded by law (including for fraud). Subject to that: we are not liable for trading or investment losses, loss of profit, or indirect or consequential loss arising from use of, reliance on, or inability to use the Service; and our total aggregate liability arising out of or in connection with the Service is limited to the fees paid by the subscriber in the twelve months preceding the event giving rise to the claim (or £1,000 where no fees have been paid).

10. General

These terms are governed by the laws of England and Wales, and the courts of England and Wales have exclusive jurisdiction. If any provision is found unenforceable, the remainder continues in effect. We may update these terms by posting a revised version with a new date; material changes to an active subscription will be notified.

Questions about these terms: institutional@neoamorfic.ai.